28                                                                                                                                                                          Daily Nation/ Thursday February 26, 2004
      Looking beyond stress while treating ulcers
By James Njoroge                                          While emotional stress and some types of food can         Researchers on herbal medicine have studied some         complete healing occurred in 44 per cent of the
              hen in school, teachers encouraged          certainly contribute to the severity of an ulcer, it is   of the local medicinal plants that are effective in      DGL group, but in only 6 per cent of placebo
                                                          patients tested positive for H pylori, while it is        now conducting a research on the efficacy of herbs
               us not to worry too much during            not the primary cause of ulcers as previously             healing of ulcers and shown that when drank like         group.
W                                                         thought.       .                                          tea, positive effects are realised.                      Unlike several synthetic drugs which temporarily
               exams or else we would develop             One study showed that at least 80 per cent of ulcer       The University of Nairobi is one of the institutions     supress the production of stomach acid, DGL
               ulcers. Many people, including med-
                                                                                                                                                                             improves the integrity of the lining of the stomach
ical practitioners, believed, a.ndstill do, that ulcers   now known that 90-100 per cent of patients with           in treating various ailments. Recently, Prof ....        and intestinal tract by increasing blood supply and ,
are caused by worrying or too much stress.                duodenal ulcers are infected with the bacteria.           Mwangi of the pharmacy department led a team of                                                                l
                                                                                                                                                                             mucosal secretions
It was not until recently that Australian research-       Ulcers are not always symptomatic, but the most           researchers in identifying suitable herbal prepara-      While acid suppressors certainly provide quick
ers first recognised the link between ulcers and          common sign reported IS burning pain between the          tions for treating ulcers.                               relief, they fail to address the underlying cause
the presence of a spiral shaped bacterium know,n          breast-bone and navel. This usually occurs shortly        Some of plants studied include Aloe vera, ginger         and cost many times more than DGL supple-
as Helicobacter pylori. This bacterium produces           after a meal or when the stomach IS empty. A few          (Zinziber officinale), licorice (glycoyrrhiza glabra)    ments. Furthermore, DGL has also demonstrated.... •
an enzyme called urease that neutralizes stomach          people complain of vomiting, diarrhoea, weight loss and some banana extract. The active ingredient of              an ability to inhibit Hpylori colonization.-
acid and allows the bacterium to thrive, penetrat-        and lack of appetite. But to reach an accurate diag-
                                                          nosis, an x-ray of the' stomach, duodenum and other licorice is glycyrrhetinic acid. But, since the com-           Another important consideration in DGL supple-
ing and damaging the protective barrier of the            tissue tests to determine the presence of H pylori        pound can elevate blood pressure, a form of licorice     mentation is that since it improves the protective
stomach lining.•                                          may be required.                                          called DGL has been found to be beneficial in the        action of the intestinal lining. Researchers are
An ulcer is a lesion or sore that forms along the         Although severe ulcers may need surgery, other          \ treatment of ulcers.                                     beginning to explore the benefits of coating aspi-
                                                                                                                    In an earlier study, 33 patients with gastric ulcers
stomach or intestinal walls. It can corrode muscles       therapies have been adopted and are recognized in                                                                  rin with licorice derivatives.
                                                                                                                    were given either DGL or a placebo three times a
and blood vessels and cause bleeding. The bacte-          the treatment of ulcers~
ria together with partially digested food can even-       There are a number of herbs which have proved to          day for one month. A ·reduction in ulcer size was       James Njoroge is a researcher with the Institute of
                                                                                                                    found in 78 per cent of the DGL group compared
tually leak into the abdominal cavity, causing            give a greater relief as a treatment for ulcers, and                                                              Herbal Medicine. Email:ihm@mailafrica.net
                                                          research is bringing new hope for ulcers patients.        to 34 per cent of the control group. In addition,
inflammation and severe pain.
                                                                                                                                                         Global Fund approves
                                                                                                                                                         voucher scheme for
                                                                                                                                                         insecticide treated nets
                                                                                                                                                         By Correspondent
                                                                                                                                                          Kenya is set to implement a voucher scheme that aims to increase
                                                                                                                                                          access of insecticide-treated nets to pregnant women and children
                                                                                                                                                          under five years, as part of the Global Fund for Malaria Initiative.
                                                                                                                                                          The scheme gives emphasis to rural and low income peri-urban com-
                                                                                                                                                          munities, with the pilot phase issuing approximately 300,000 nets and
                                                                                                                                                          600,000 re-treatment kit vouchers.
                                                                                                                                                          Population Services International (PSI), a social marketing organisa-
                                                                                                                                                          tion that has been involved in marketing of ITNs in Kenya, has been
                                                                                                                                                          appointed to implement the project in four districts .
                                                                                                                                                        . The Ministry of Health wilI select four malaria-endemic districts in the
                                                                                                                                                          first phase, which will test the scheme and iron out potential problems
                                                                                                                                                          prior to a progressive roll-out to other districts.
                                                                                                                                                          The plan is to distribute up to two million vouchers Over five years to
                                                                                                                                                          pregnant women and children under five years who visit clinics.
                                                                                                                                                          The eligible people wilI get vouchers from the clinics, which they will
                                                                                                                                                          then take to a nearby retail outlet and pick a net or re-treatment kit.
                                                                                                                                                          The voucher will give them a discount on the commercial price for the
                                                                                                                                                          value of the voucher.
                                                                                                                                                          According to Dana Tilson, the ITN Technical Advisor at PSI, a net
                                                                                                                                                          voucher wilI be worth about Sh 160 while the re-treatment kit voucher
                                                                                                                                                          wilI be worth Sh 30. In the pilot phase that will run for one year, only
                                                                                                                                                          government and some mission clinics will dispense the vouchers.
                                                                                                                                                          The Ministry of Health will manage the distribution of vouchers to
                                                                                                                                                          clinics on a monthly or quarterly basis.
                                                                                                                                                          Participating retail and wholesale outlets will be pre-selected and their
                                                                                                                                                          owners trained. They will then sign an agreement about conditions of
                                                                                                                                                          voucher sales. A logo will be designed to identify participating out-
                                                                                                                                                          lets.
                                                                                                                                                          Kenya to host three more Aids
                                                                                                                                                          vaccine trials in next two years
                                                                                                                                                          CONTINUED FROM PAGE 23
                                                                                                                                                          in developing countries because of the UNAIDs requirement.
                                                                                                                                                          UNAIDS, some scientists claim, is also realizing that this condition
                                                                                                                                                          may work against moves to accelerate the development of a preven-
                                                                                                                                                          tive Aids vaccine.
                                                                                                                                                          "The organisation is agreeing with some of us that in cases where sci-
                                                                                                                                                          entists in the host country can independently study the science behind
                                                                                                                                                          a vaccine developed in the US, and if it is appropriate, then it can be
                                                                                                                                                          tested in Kenya before testing in the US."
                                                                                                                                                          At the moment, this is the practice in the developed world, where
                                                                                                                                                          products developed in the US are being tested in Sweden, which has
                                                                                                                                                          a huge pool of experts on vaccine development.
                                                                                                                                                          To boost Kenya's capability to handle the new vaccine trial and
                                                                                                                                                          research on infectious diseases, Manitoba University of Canada is
                                                                                                                                                          planning to build multimillion shilling state-of-the-art research labora-
                                                                                                                                                          tories at the University of Nairobi.
                                                                                                                                                          According to Dr Walter Jaoko, the laboratories, to be known as the
                                                                                                                                                          Institute of Tropical Medicine and Infectious Diseases, are to put
                                                                                                                                                           Kenya on the infectious diseases research map, with tests such Ebola
                                                                                                                                                          and Rift Valley Fever, that hitherto specimen have had to be flown
                                                                                                                                                          abroad for analysis, being done here.
                                                                                                                                                           Meanwhile, the Canadian Aids Vaccine Group's vaccine has already
                                                                                                                                                          been tested in animal models as required by scientific guidelines
                                                                                                                                                          before tests move to human beings- and proved to be safe and able to
                                                                                                                                                          elicit immune responses to HIV.
                                                                                                                                                          The vaccine is designed to elicit immune responses in the so-called
                                                                                                                                                          mucosal surfaces. These surfaces are some of the points where HIV
                                                                                                                                                          enters the body.
                                                                                                                                                          They are present in the vaginal tract and the rectum, eXplaining why
                                                                                                                                                          most of the infections take place through sexual intercourse. The
                                                                                                                                                          gastro-intestinal tract also has a mucosal lining.
                                                                                                                                                           Indeed, the HIV infection that a child acquires from an infected
                                                                                                                                                           mother during breastfeeding finds its way to the baby's body through
                                                                                                                                                           the mucosal surface of his or her gut.
                                                                                                                                                          - An A we Feature
Page 


-------------------Trial Version-----------------------

Convert PDF to Text Desktop Software.

Copyright Convertpdftotext.net 2014.

To remove these lines, please activate your software from http://www.convertpdftotext.net/buynow.htm

-------------------------------------------------------
